Tazidime and Rabeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tazidime (ceftazidime) and Rabeprazole (rabeprazole sodium). Common drug interactions include melaena among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Tazidime and Rabeprazole. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.



On Jul, 26, 2026

77 people who take Tazidime and Rabeprazole together, and have interactions are studied.

Tazidime and Rabeprazole drug interactions.

What are the common drug interactions of Tazidime and Rabeprazole, by gender? *:

female:

  1. Melaena (the passage of black, tarry stools)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Adverse reaction
  4. Alopecia (absence of hair from areas of the body)
  5. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Aspartate aminotransferase increased
  8. Blood glucose increased
  9. Blood potassium increased
  10. Chest pain

male:

  1. Renal failure (kidney dysfunction)
  2. Hypertension (high blood pressure)
  3. Confusional state
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Dizziness
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Fungal infection
  8. Headache (pain in head)
  9. Hydrocephalus (water on the brain)
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Tazidime and Rabeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Dystonia (abnormal muscle tone)

20-29:

  1. Hypertension (high blood pressure)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Infection
  4. Insomnia (sleeplessness)
  5. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Post transplant lymphoproliferative disorder
  8. Pulmonary alveolar haemorrhage (acute bleeding)
  9. Renal failure (kidney dysfunction)
  10. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)

30-39:

  1. Cellulitis (infection under the skin)
  2. Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Fungal infection
  5. Renal failure (kidney dysfunction)
  6. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)

40-49:

  1. Breath sounds
  2. Cardiac failure
  3. Cerebral haemorrhage (bleeding within the brain)
  4. Confusional state
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Dizziness
  7. Headache (pain in head)
  8. Hydrocephalus (water on the brain)
  9. Hypertension (high blood pressure)
  10. Hypotension (abnormally low blood pressure)

50-59:

  1. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  2. Diarrhoea
  3. Gastroenteritis (inflammation of stomach and intestine)
  4. Haemoglobin decreased
  5. Vomiting
  6. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  7. Bone marrow failure
  8. Cytomegalovirus enterocolitis (virus infection of intestine and colon)
  9. Immunodeficiency
  10. Intestinal perforation (complete penetration of the wall of the intestine)

60+:

  1. Hepatocellular injury (liver injury)
  2. Nausea (feeling of having an urge to vomit)
  3. Liver injury
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Rash
  6. Weight decreased
  7. Anaemia (lack of blood)
  8. Asthenia (weakness)
  9. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  10. Abdominal pain upper

What are the existing conditions these people have? *

  1. Depression: 13 people, 16.88%
  2. High Blood Pressure: 10 people, 12.99%
  3. Constipation: 7 people, 9.09%
  4. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 7.79%
  5. Hyperglycemia (high blood sugar): 6 people, 7.79%
  6. Asthma: 5 people, 6.49%
  7. Febrile Neutropenia (fever with reduced white blood cells): 5 people, 6.49%
  8. Insomnia (sleeplessness): 5 people, 6.49%
  9. Vitamin B12 Deficiency: 4 people, 5.19%
  10. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 5.19%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and Rabeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tazidime and Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tazidime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime and rabeprazole sodium (the active ingredients of Tazidime and Rabeprazole, respectively), and Tazidime and Rabeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: